Healthcare - Biotechnology - NYSE - US
$ 1.36
0.741 %
$ 3.78 M
Market Cap
-0.04
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
43.66%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Theriva Biologics, Inc.
TOVX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TOVX
EBIT FORECAST
EBIT Forecast Chart TOVX
NET INCOME FORECAST
Net Income Chart TOVX